Traitomic raises €20 million to accelerate market-ready trait development
First external investment in the company since its spin-out from Carlsberg
Round led by Sofinnova Partners, with participation from the Export and Investment Fund of Denmark (EIFO), Footprint Firm, Nordic Foodtech VC, PSV Hafnium and SVG Ventures
Funding to accelerate international expansion and expand integrated trait development capabilities
Copenhagen, Denmark, 17 November 2026 - Traitomic, a Danish biotechnology company developing market-ready, non-GE/non-GM traits in plants and microorganisms, has raised €20 million in a Series A round led by Sofinnova Partners. The investor consortium also includes the Export and Investment Fund of Denmark (EIFO), Footprint Firm, Nordic Foodtech VC, PSV Hafnium and SVG Ventures. The round marks Traitomic's first external investment since its spin-out from Carlsberg and follows the development of a growing customer base across multiple industries. The funding will support international expansion and continued development of the company's scientific and commercial capabilities.
The world increasingly depends on improved biological performance to address challenges in food security, resource efficiency and sustainability. Yet translating a biological need into a commercially relevant trait can be slow, fragmented and difficult to scale. Traitomic helps bridge that gap not only by developing market-ready traits, but also supporting customers from initial commercial challenges through to deployment.
Traitomic’s proprietary FIND-IT platform identifies specific genetic variants in conventionally bred populations without gene editing, enabling rapid trait development while maintaining broad regulatory and commercial applicability. Unlike many trait-development approaches that are tailored to specific organism types, the platform can be applied across both plant and microbial systems.
To date, Traitomic has delivered 116 traits to 47 customers across 32 organisms spanning plant breeding and seed; food supply chain and precision nutrition; and biosolutions and industrial biotech. The projects range from improving crop robustness and yield, to developing differentiated food products with enhanced flavour, nutrition or shelf life, and optimising enzymes and strains used in industrial biotechnology. This breadth of applications reflects demand from customers across multiple industries and highlights the significant opportunity to expand trait development across the broader bioeconomy.
The funding will support Traitomic's international expansion and help the company capture this opportunity across food, agriculture and biosolutions markets. In addition, Traitomic will continue to broaden its integrated offering, enabling closer collaboration with customers from initial biological or commercial challenges through delivery of market-ready traits.
Gustav Hambraeus, CEO and co-founder, Traitomic said: "This investment marks the beginning of Traitomic's next chapter. Over the past years, we have demonstrated that customers across the food value chain are looking for faster routes from biological insight to commercial impact. With the support of our new investors, we can now expand internationally, deepen our collaboration with customers and bring our integrated approach to trait development to many more innovation challenges."
Michael Krel, Partner, Sofinnova Partners said: "Traitomic has demonstrated something that is rare in biological innovation: the ability to develop commercially relevant traits across a broad range of organisms and applications. Combined with the company's strong customer traction and proven track record, this creates a compelling foundation for future growth. We believe Traitomic is well positioned to become a leading partner for trait development across agriculture, food and industrial biotechnology, and we look forward to supporting the team with both capital and experience as they enter their next phase of international expansion."
Anders Røed, Executive Vice President, Group Strategy and Commercial, Carlsberg said: "Traitomic is an excellent example of how fundamental research can create value far beyond its original field of application. FIND-IT was developed at Carlsberg Research Laboratory to improve barley, and it is now enabling advances in agriculture, food production and industrial biotechnology. I am proud of what the team has achieved and excited to continue supporting the company as it enters this next phase of international growth.”
About Traitomic
Traitomic is a Danish biotechnology company specialising in trait discovery and development in plants and microorganisms. Spun out of Carlsberg, the company combines scientific expertise with its proprietary FIND-IT technology, to enable precise, non-GE/non-GM trait development. Traitomic works with customers worldwide across food, agriculture and biosolutions, providing tailored support from trait discovery and development through to assessment and handover.
For more information, visit www.traitomic.com.
About the Carlsberg Group
Established in 1847 by brewer J.C. Jacobsen, the Carlsberg Group is one of the leading beverage companies in the world, with an attractive portfolio of beer, soft drinks and other beverage brands. With over 35,000 employees, and with a presence in more than 150 markets, the Group has a purpose of brewing for a better today and tomorrow. Doing business responsibly and sustainably supports that purpose – and drives the efforts to deliver value for employees, consumers, customers and society. For further information, visit carlsberggroup.com or follow the Carlsberg Group on LinkedIn.
About Sofinnova Partners
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life-sciences investments, from seed to later-stage. Founded in 1972, Sofinnova Partners has over 50 years of experience backing over 500 companies and creating market leaders around the globe. Today, Sofinnova Partners manages over €4 billion in assets. For more information, please visit: sofinnovapartners.com.
About EIFO - Export and Investment Fund of Denmark
EIFO works to help Danish companies grow and do business in Denmark and around the world. We open doors to global opportunities, drive the green transition, support innovative technologies, and contribute to Denmark’s security.
As Denmark’s national promotional bank, official export credit agency and largest venture investor, EIFO provides loans, guarantees and investments to companies ranging from startups to global corporations. With a total exposure of more than 24 billion euro, we are active in more than 100 countries.
About Nordic Foodtech VC
Nordic Foodtech VC is the first Nordic VC fund focused on solutions for the agriculture and food industries. The company manages two funds: a €42 million fund launched in 2020 and a second 80€M fund launched in 2025.
Nordic Foodtech VC invests in early-stage companies that aim to make a positive impact by solving business-critical challenges in the food system, ranging from soil to orbit and from new sources of protein to healthier eating habits. Initial investments are up to €2 million, with significant reserves for follow-on investments. We believe in solving the hard underlying problems in food and farming with new technology built on scientific discovery and solid engineering – the deep foodtech.
The team is based in Helsinki and Copenhagen and operates across Europe.
About PSV Hafnium
PSV Hafnium is a Copenhagen-based early-stage deep tech venture fund with a Nordic focus. The fund takes early bets on scientists, engineers and entrepreneurs and, drawing on a comprehensive understanding of the startup journey, patiently helps founders scale unproven technological breakthroughs into impactful global solutions. The GP team comprises Anders Kjær, Jakob Rybak-Andersen, Maria Emilie Kath Danø and Marianne Hyltoft. PSV Hafnium is part of the PSV Venture House.
Learn more at www.psv.xyz/hafnium.
About The Footprint Firm
The Footprint Firm was founded in 2019 and is a leading Danish sustainability strategy advisory and venture capital firm. The Footprint Firm advises private companies, investors, public institutions and research institutions, and manages €76m in assets under Footprint Fund I, operating with a 35-member team based in Copenhagen.
This press release was distributed through Protein Report Newswire. For media inquiries, contact Traitomic directly.